Revolution Medicines, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Rok finansowy 2018 2019 2019 2019 2019 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025
Kwartał Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1
Data 2018-12-31 2019-03-31 2019-06-30 2019-09-30 2019-12-31 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 10 13 12 13 12 12 10 13 9 10 9 1 9 8 9 3 15 7 4 0 1 0 0 0 0 0
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 16.8% -12.30% -18.37% 1.2% -27.61% -12.26% -13.24% -91.30% 8.1% -25.20% 4.8% 204.8% 62.1% -7.44% -58.05% -100.00% -95.16% -100.00% -100.00% 0.0% -100.00% 0.0%
Marża brutto -75.71% -60.91% -63.81% -83.61% -127.42% -137.81% -228.36% -175.42% -322.88% -303.30% -428.12% -4120.98% 78.2% 69.8% 74.4% -1969.58% 83.0% 63.9% 53.6% -inf% -285.18% -inf% -inf% 0.0% 0.0% 0.0%
Koszty i Wydatki (mln) 22 24 23 26 32 33 38 40 43 48 53 54 62 66 71 80 77 82 113 123 181 141 157 176 216 241
EBIT (mln) -12 -10 -11 -14 -20 -21 -28 -28 -34 -37 -45 -53 -53 -58 -62 -77 -62 -75 -109 -123 -180 -141 -157 -176 -216 -241
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 67.7% 102.0% 165.0% 103.2% 74.2% 77.4% 59.1% 93.0% 55.3% 55.0% 39.4% 44.0% 16.6% 29.7% 75.2% 61.0% 191.7% 87.4% 44.0% 42.6% 20.2% 70.9%
EBIT (%) -112.78% -79.26% -85.99% -108.42% -161.85% -182.59% -279.14% -217.61% -389.44% -369.13% -512.01% -4828.61% -559.33% -764.70% -681.10% -2280.48% -402.52% -1071.53% -2845.11% 0.0% -24256.47% 0.0% 0.0% 0.0% 0.0% nan
Przychody fiansowe (mln) 0 0 0 1 1 1 1 0 0 0 0 0 0 0 1 3 5 7 10 11 19 24 21 20 21 25
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 9 0 0 0 0 0
Amortyzacja (mln) 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 2 3 3 2 2 3 2 2 0 3 4
EBITDA (mln) -11 -9 -9 -12 -18 -19 -26 -26 -32 -35 -42 -51 -51 -56 -60 -71 -54 -73 -107 -121 -158 -139 -155 -176 -213 -237
EBITDA(%) -102.59% -70.70% -75.56% -95.31% -149.58% -161.35% -255.19% -201.99% -386.56% -350.27% -488.14% -4649.32% -556.83% -730.50% -645.99% -2121.36% -369.41% -1071.53% -2845.11% 0.0% -23871.29% 0.0% 0.0% 0.0% 0.0% nan
NOPLAT (mln) -11 -10 -10 -13 -19 -20 -27 -27 -34 -37 -44 -53 -53 -58 -61 -74 -57 -68 -98 -112 -161 -116 -133 -156 -195 -213
Podatek (mln) 0 0 0 1 -4 -1 -0 0 0 0 0 0 -2 -0 -1 -0 -0 -10 -2 4 0 0 0 0 -1 0
Zysk Netto (mln) -11 -10 -10 -13 -15 -20 -27 -27 -34 -37 -44 -53 -53 -57 -60 -73 -57 -59 -98 -108 -162 -116 -133 -156 -195 -213
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 28.7% 92.7% 168.9% 112.4% 134.3% 90.5% 62.8% 94.5% 54.0% 54.3% 36.2% 38.5% 7.3% 2.0% 62.9% 47.9% 185.9% 98.3% 35.5% 44.1% 20.4% 84.0%
Zysk netto (%) -109.59% -76.95% -82.40% -102.49% -120.75% -169.05% -271.47% -215.00% -390.86% -366.95% -509.30% -4808.36% -556.83% -756.73% -662.08% -2185.01% -368.60% -834.13% -2570.55% 0.0% -21770.49% 0.0% 0.0% 0.0% 0.0% nan
EPS -0.31 -0.28 -0.28 -0.35 -0.4 -0.67 -0.46 -0.42 -0.52 -0.53 -0.6 -0.72 -0.71 -0.77 -0.81 -0.87 -0.63 -0.62 -0.92 -0.99 -1.14 -0.7 -0.81 -0.94 0.0 -1.13
EPS (rozwodnione) -0.31 -0.28 -0.28 -0.35 -0.4 -0.67 -0.46 -0.42 -0.52 -0.53 -0.6 -0.72 -0.71 -0.77 -0.81 -0.87 -0.63 -0.62 -0.92 -0.99 -1.14 -0.7 -0.81 -0.94 0.0 -1.13
Ilośc akcji (mln) 36 36 36 36 36 29 59 65 66 70 73 74 74 74 74 85 89 95 107 109 141 165 165 167 0 188
Ważona ilośc akcji (mln) 36 36 36 36 36 29 59 65 66 70 73 74 74 74 74 85 89 95 107 109 141 165 165 167 0 188
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD